Amsurg Corp (AMSG) is Reiterated by Mizuho to Buy, Raises Price Target to $ 95

Amsurg Corp (AMSG) was Reiterated by Mizuho to “Buy” according to the research note released today. The brokerage firm has raised the Price Target to $ 95 from a previous price target of $90 . Mizuho advised their investors in a research report released on Jun 24, 2016.

Many Wall Street Analysts have commented on Amsurg Corp. Amsurg Corp was Upgraded by BofA/Merrill to ” Buy” on Jun 16, 2016. Amsurg Corp was Initiated by Wells Fargo to “Market Perform” on Jun 15, 2016. Company shares were Reiterated by Mizuho on May 4, 2016 to “Buy”, Firm has raised the Price Target to $ 90 from a previous price target of $84 .

On the company’s financial health, Amsurg Corp reported $0.82 EPS for the quarter, beating the analyst consensus estimate by $ 0.04 according to the earnings call on May 3, 2016. Analyst had a consensus of $0.78. The company had revenue of $724.70 million for the quarter, compared to analysts expectations of $702.21 million. The company’s revenue was up 27.1% compared to the same quarter last year. During the same quarter in the previous year, the company posted $0.62 EPS.

Amsurg Corp closed down -0.38 points or -0.47% at $80.42 with 8,58,308 shares getting traded on Tuesday. Post opening the session at $81.15, the shares hit an intraday low of $79.39 and an intraday high of $81.2399 and the price fluctuated in this range throughout the day.Shares ended Tuesday session in Red.

In a different news, on Sep 3, 2015, Christopher A Holden (President and CEO) sold 3,000 shares at $77.00 per share price. According to the SEC, on Aug 17, 2015, Claire M Gulmi (Executive VP & CFO) sold 15,000 shares at $84.74 per share price. On Aug 11, 2015, Robert Jon Coward (Executive Vice President) sold 30,000 shares at $83.23 per share price, according to the Form-4 filing with the securities and exchange commission.

AmSurg Corp. is the owner and operator of ambulatory surgery centers (ASCs) in the United States. The Company is also a provider of outsourced physician services in the areas of anesthesiology children’s services emergency medicine and radiology. The Company operates in two segments: ambulatory surgery services and outsourced physician services. The ambulatory services segment which acquires develops and operates ambulatory surgery centers in partnership with physicians. The physician services segment which provides outsourced physician services in multiple specialties to hospitals ambulatory surgery centers and other healthcare facilities primarily in the areas of anesthesiology children’s services emergency medicine and radiology. It operated approximately 246 ASCs in over 34 states and the District of Columbia in partnership with approximately 2000 physicians and provided physician services to over 320 healthcare facilities in 24 states.

Amsurg Corp

Leave a Reply

Amsurg Corp - Is it time to Sell?

Top Brokerage Firms are advising their investors on Amsurg Corp. Subscribe to MoneyFlowIndex.Org Pre-Market Alerts, You will be the first to know the street buzz.